Cost Minimization of Medicare Part D Prescription Drug Plan Expenditures

被引:0
|
作者
Patel, Rajul A. [1 ]
Lipton, Helene Levens [2 ]
Cutler, Timothy W. [2 ]
Smith, Amanda R. [2 ]
Tsunoda, Shirley M. [3 ]
Stebbins, Marilyn R. [2 ]
机构
[1] Univ Pacific, Dept Pharm Practice, Stockton, CA 95211 USA
[2] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA
[3] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA
来源
AMERICAN JOURNAL OF MANAGED CARE | 2009年 / 15卷 / 08期
关键词
TRIAL;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To minimize out-of-pocket prescription drug plan (PDP) expenditures by Medicare beneficiaries. Study Design: Cost-minimization analysis. Methods: Trained student pharmacists from 6 California pharmacy schools provided expert guidance on Medicare Part D PDPs to beneficiaries through interventions at statewide outreach events. Demographic and insurance information for 2008 was collected via survey. Cost information for the beneficiary's current PDP for 2008 and for the least expensive PDP for 2008 was obtained using the Medicare Plan Finder tool (http://www.medicare.gov). Results: Data were collected from 250 beneficiaries at 22 outreach events. For the cost-minimization analysis, data were excluded from 72 beneficiaries who were not enrolled in a stand-alone PDP before the intervention and from another 23 beneficiaries for whom information regarding their current PDP or prescription drug profile was incomplete. Of the remaining 155 study participants, 39.4% were male, the mean (SD) age was 74.6 (8.7) years, and they were taking a mean (SD) of 5.3 (3.5) prescription drugs each month. In addition, 68 beneficiaries (43.9%) had limited or no English proficiency, and 85 beneficiaries (54.8%) were enrolled in both Medicare and Medicaid. In total, 89.7% of beneficiaries could have realized cost savings by switching to a different PDP. The median annual potential cost savings was $98 per beneficiary but this varied as a function of subsidy level. Conclusion: Targeted community outreach services to Medicare Part D beneficiaries can help optimize patient selection of a PDP, thereby resulting in lower out-of-pocket expenditures. (Am J Manag Care. 2009; 15(8):545-553)
引用
收藏
页码:545 / 553
页数:9
相关论文
共 50 条
  • [41] Impact of Medicare Part D on Utilization and Expenditures
    Nair, Kavita V.
    Jan, Saira A.
    Wolfe, Pamela
    Allen, Richard Read
    Saseen, Joseph J.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2010, 2 (03) : 209 - +
  • [42] Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis
    Park, Haesuk
    Rascati, Karen L.
    Lawson, Kenneth A.
    Barner, Jamie C.
    Richards, Kristin M.
    Malone, Daniel C.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (10): : 956 - +
  • [43] Medicare prescription drug plan costs and affordability - 2007
    Davis, Matthew M.
    Patel, Mitesh S.
    Halasyamani, Lakshmi K.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 (08) : 1221 - 1222
  • [44] Medicare Prescription Drug Plan Costs and Affordability—2007
    Matthew M. Davis
    Journal of General Internal Medicine, 2007, 22 : 1221 - 1222
  • [45] The relationship between plan characteristics and Medicare Prescription Drug Plan bids
    Dai, Rui
    Robst, John
    APPLIED ECONOMICS LETTERS, 2012, 19 (01) : 99 - 104
  • [46] EVALUATING DRUG COST AND RESTRICTION PROCESSES OF COMMONLY USED PRESCRIPTION DRUGS UNDER EACH 2011 CALIFORNIA STAND-ALONE MEDICARE PART D PLAN
    Patel, R.
    Kim, M. J.
    Walberg, M.
    Woelfel, J.
    VALUE IN HEALTH, 2011, 14 (03) : A19 - A19
  • [47] Prescription drug coverage and effects on drug expenditures among elderly medicare beneficiaries
    Huh, Soonim
    Rice, Thomas
    Ettner, Susan L.
    HEALTH SERVICES RESEARCH, 2008, 43 (03) : 810 - 832
  • [48] Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures
    Tisdale, Rebecca L.
    Ma, Iris
    Vail, Daniel
    Bhattacharya, Jay
    Goldhaber-Fiebert, Jeremy D.
    Heidenreich, Paul A.
    Sandhu, Alexander T.
    JAMA NETWORK OPEN, 2021, 4 (06)
  • [49] Physicians' views regarding prescription drug access under medicare Part D
    Epstein, A. J.
    Rathore, S. S.
    Alexander, G. C.
    Ketcham, J. D.
    VALUE IN HEALTH, 2008, 11 (03) : A41 - A41
  • [50] Differential take-up of the medicare part D prescription drug benefit
    Rabbani, A.
    Yin, W.
    Zhang, J. X.
    Sun, S. X.
    Alexander, G. C.
    VALUE IN HEALTH, 2008, 11 (03) : A12 - A13